Increasing Prevalence Of Diabetes Fuels Growth In The Pen Needles Market Emerges as a Core Driver of the Pen Needles Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Pen Needles Market Through 2025?
Over the previous years, the size of the pen needles market has been witnessing a quick expansion. It is projected to increase from $2.42 billion in 2024 to a significant $2.69 billion in 2025, showcasing a compound annual growth rate (CAGR) of 11.1%. Key factors contributing to this remarkable growth during the historic period are the development of the insulin pen, advancements in miniaturization technology, heightened emphasis on patient comfort, improvements in needle design, and the application of safety features.

What's the Projected Size of the Global Pen Needles Market by 2029?
The market for pen needles is predicted to witness substantial expansion in the upcoming years. It's projected to inflate to a worth of $4.01 billion by 2029, reflecting a compound annual growth rate (CAGR) of 10.5%. Factors such as compatibility with various insulin pens, customization facilities, advancements in materials, incorporation with digital health tools, and regulatory requirements and measures are contributing to the growth expected in the forecast duration. The predictions for this period also point towards notable trends such as user-centric designs, elevated needle coverings, the use of eco-friendly materials, and the integration of intelligent technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pen-needles-global-market-report

Top Growth Drivers in the Pen Needles Industry: What's Accelerating the Market?
The escalating occurrence of diabetes is predicted to boost the expansion of the pen needles market in the future. The persistence of diabetes as a health concern characterized by elevated blood sugar levels arises from insufficient insulin production or inefficient insulin use by the body. Moreover, the increasing instance of diabetes can be traced back to factors like stationary lifestyles, unhealthy eating habits, genetic vulnerability, urbanization, and aging populations. Additionally, limited healthcare accessibility and escalating obesity rates worldwide exacerbate the situation. Pen needles have become crucial tools in diabetes management, facilitating accurate insulin administration via accessible, minimally invasive injections. This not only results in improved glycemic control but also reinforces patient adherence. For example, information from the Belgium-based International Diabetes Federation in 2021 projects a rise in the number of people living with diabetes to 643 million by 2030 and 783 million by 2045. Hence, the escalating incidence of diabetes is fueling the expansion of the pen needles market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15632&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Pen Needles Market?
Leading firms in the pen needle market are concentrating on the advancement of innovative technologies, such as thin-wall technology, in order to lessen the requirement for pressure during the injection process. Thin-wall technology refers to a needle design that increases the internal diameter for the purpose of faster flow of medication with lesser injection pressure, ultimately enhancing patient comfort. For example, in May 2022, Roche Diabetes Care Ltd., a pharmaceutical company based in Switzerland, introduced ACCU-FINE pen needles, engineered to offer virtually pain-free insulin delivery. The ACCU-FINE needles possess a unique cut that eases insertion and a specialized coating that supports smooth gliding into the skin, reducing discomfort during injections. The needles have a thin wall, enabling quicker insulin flow and hence ensuring an effective delivery of medication. Every needle comes with two protective covers, a sealed sterile protective cap and an added protective cap to guarantee safe handling and storage. ACCU-FINE needles are compatible with all commonly used insulin pens, making them adaptable for different users irrespective of their specific insulin delivery device.

What Are the Main Segments in the Pen Needles Market?
The pen needles market covered in this report is segmented -

1) By Type: Standard Pen Needles, Safety Pen Needles
2) By Needle Length: Short Length Pen Needles, Medium Length Pen Needles, Long Length Pen Needles
3) By Therapy: Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone
4) Mode Of Purchase: Retail, Non-Retail
5) By End User: Hospitals And Clinics, Home Healthcare, Other End Users

Subsegments:
1) By Standard Pen Needles: Fixed-Needle Pen Needles, Removable-Needle Pen Needles, Short Pen Needles ( 4mm, 5mm), Long Pen Needles ( 8mm, 12mm)
2) By Safety Pen Needles: Automatic Safety Pen Needles, Manual Safety Pen Needles, Retractable Safety Pen Needles, Shielded Safety Pen Needles

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15632&type=smp

Which Top Companies are Driving Growth in the Pen Needles Market?
Major companies operating in the pen needles market are Cardinal Health Inc., Novartis AG, F. Hoffmann-La Roche AG, Novo Nordisk AS, Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Artsana Group, Embecta Corp., Tandem Diabetes Care Inc., Trividia Health Inc., Medical Technology and Devices S.p.A., Owen Mumford, Dynarex Corporation, Arkray Inc., UltiMed Inc., Montmed Inc., Bio-Med HealthCare Products Pvt. Ltd., Allison Medical Inc., GlucoRx Ltd., Simple Diagnostics Inc., Stat Medical Inc., HTL-STREFA S.A., Hindustan Syringes & Medical Devices Ltd.

Which Regions Will Dominate the Pen Needles Market Through 2029?
North America was the largest region in the pen needles market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pen needles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15632

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.